Taiwan · Delayed Price · Currency is TWD Dr. Wu Skincare Statistics
Total Valuation
Dr. Wu Skincare has a market cap or net worth of TWD 4.05 billion. The enterprise value is 3.08 billion.
| Market Cap | 4.05B |
| Enterprise Value | 3.08B |
Important Dates
The next estimated earnings date is Friday, November 6, 2026.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | Jul 1, 2026 |
Share Statistics
Dr. Wu Skincare has 45.05 million shares outstanding. The number of shares has decreased by -0.09% in one year.
| Current Share Class | 45.05M |
| Shares Outstanding | 45.05M |
| Shares Change (YoY) | -0.09% |
| Shares Change (QoQ) | -0.74% |
| Owned by Insiders (%) | 22.10% |
| Owned by Institutions (%) | 1.83% |
| Float | 16.63M |
Valuation Ratios
The trailing PE ratio is 13.64.
| PE Ratio | 13.64 |
| Forward PE | n/a |
| PS Ratio | 3.77 |
| PB Ratio | 3.18 |
| P/TBV Ratio | 3.18 |
| P/FCF Ratio | 10.96 |
| P/OCF Ratio | 10.79 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.81, with an EV/FCF ratio of 8.35.
| EV / Earnings | 10.36 |
| EV / Sales | 2.87 |
| EV / EBITDA | 9.81 |
| EV / EBIT | 10.09 |
| EV / FCF | 8.35 |
Financial Position
The company has a current ratio of 3.83, with a Debt / Equity ratio of 0.03.
| Current Ratio | 3.83 |
| Quick Ratio | 3.30 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.11 |
| Debt / FCF | 0.10 |
| Interest Coverage | 243.63 |
Financial Efficiency
Return on equity (ROE) is 22.06% and return on invested capital (ROIC) is 66.58%.
| Return on Equity (ROE) | 22.06% |
| Return on Assets (ROA) | 10.98% |
| Return on Invested Capital (ROIC) | 66.58% |
| Return on Capital Employed (ROCE) | 23.52% |
| Weighted Average Cost of Capital (WACC) | 4.09% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.62 |
| Inventory Turnover | 2.06 |
Taxes
In the past 12 months, Dr. Wu Skincare has paid 73.02 million in taxes.
| Income Tax | 73.02M |
| Effective Tax Rate | 19.69% |
Stock Price Statistics
The stock price has decreased by -25.70% in the last 52 weeks. The beta is -0.03, so Dr. Wu Skincare's price volatility has been lower than the market average.
| Beta (5Y) | -0.03 |
| 52-Week Price Change | -25.70% |
| 50-Day Moving Average | 93.18 |
| 200-Day Moving Average | 108.99 |
| Relative Strength Index (RSI) | 42.24 |
| Average Volume (20 Days) | 27,079 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dr. Wu Skincare had revenue of TWD 1.07 billion and earned 297.83 million in profits. Earnings per share was 6.59.
| Revenue | 1.07B |
| Gross Profit | 717.19M |
| Operating Income | 305.75M |
| Pretax Income | 370.86M |
| Net Income | 297.83M |
| EBITDA | 311.48M |
| EBIT | 305.75M |
| Earnings Per Share (EPS) | 6.59 |
Balance Sheet
The company has 1.00 billion in cash and 35.55 million in debt, with a net cash position of 965.05 million or 21.42 per share.
| Cash & Cash Equivalents | 1.00B |
| Total Debt | 35.55M |
| Net Cash | 965.05M |
| Net Cash Per Share | 21.42 |
| Equity (Book Value) | 1.27B |
| Book Value Per Share | 28.43 |
| Working Capital | 974.71M |
Cash Flow
In the last 12 months, operating cash flow was 375.22 million and capital expenditures -5.78 million, giving a free cash flow of 369.44 million.
| Operating Cash Flow | 375.22M |
| Capital Expenditures | -5.78M |
| Depreciation & Amortization | 5.73M |
| Net Borrowing | -10.57M |
| Free Cash Flow | 369.44M |
| FCF Per Share | 8.20 |
Margins
Gross margin is 66.73%, with operating and profit margins of 28.45% and 27.71%.
| Gross Margin | 66.73% |
| Operating Margin | 28.45% |
| Pretax Margin | 34.50% |
| Profit Margin | 27.71% |
| EBITDA Margin | 28.98% |
| EBIT Margin | 28.45% |
| FCF Margin | 34.37% |
Dividends & Yields
This stock pays an annual dividend of 8.00, which amounts to a dividend yield of 8.90%.
| Dividend Per Share | 8.00 |
| Dividend Yield | 8.90% |
| Dividend Growth (YoY) | -9.09% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 151.25% |
| Buyback Yield | 0.09% |
| Shareholder Yield | 8.99% |
| Earnings Yield | 7.35% |
| FCF Yield | 9.12% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 26, 2016. It was a forward split with a ratio of 1.5.
| Last Split Date | May 26, 2016 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |